Anthony V. Moorman

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 137 publications

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

Journal: Blood advances
Published: May 07, 2026

B-cell precursor acute lymphoblastic leukemia with IGH::CEBP rearrangement: what have we learnt over the years?

B-cell precursor acute lymphoblastic leukemia with IGH::CEBP rearrangement: what have we learnt over the years?

Journal: Haematologica
Published: December 24, 2025

Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.

Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.

Journal: Cancer cell international
Published: November 07, 2025

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia
Published: October 06, 2025

International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

Journal: Nature communications
Published: June 10, 2025

Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts.

Benchmarking the paediatric T-cell ALL subtype classifier, TALLSorts.

Journal: British journal of haematology
Published: June 02, 2025

DUX4-rearranged B-ALL: deciphering a biological and clinical conundrum.

DUX4-rearranged B-ALL: deciphering a biological and clinical conundrum.

Journal: Leukemia
Published: March 06, 2025

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.

Journal: Leukemia
Published: October 18, 2024

ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study.

ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study.

Journal: British journal of cancer
Published: September 09, 2024

Excised DNA circles from V(D)J recombination promote relapsed leukaemia.

Excised DNA circles from V(D)J recombination promote relapsed leukaemia.

Journal: Nature
Published: June 26, 2024

A dedicated caller for DUX4 rearrangements from whole-genome sequencing data.

A dedicated caller for DUX4 rearrangements from whole-genome sequencing data.

Journal: BMC medical genomics
Published: June 06, 2024

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.

Journal: Leukemia
Published: May 06, 2024
Showing 1-12 of 137

Last Updated: 09/26/2026